Neha Krishnamohan Insider Profile

4 Followers
Neha Krishnamohan, CFO at Kinnate Biopharma, holds 50.00K shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV), holds 15.75K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 0.00 shares in Kinnate Biopharma (Ticker: KNTE).
tipranks
Neha Krishnamohan

Neha Krishnamohan
Kinnate Biopharma (KNTE)
CFO

Not Ranked
Neha Krishnamohan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$840K
79.67%
20.33%
A breakdown of Neha Krishnamohan's holdings

Insider Roles

Artiva Biotherapeutics, Inc.
(ARTV)
Chief Financial Officer
Arcutis Biotherapeutics
(ARQT)
Director
Roles that Neha Krishnamohan holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Neha Krishnamohan

Neha Krishnamohan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KNTE
Kinnate Biopharma
Apr 05, 2024
Uninformative Sell
$0.00
Arcutis Biotherapeutics
Jun 18, 2024
Director
Uninformative Buy
$170.69K
Artiva Biotherapeutics, Inc.
Sep 13, 2024
Chief Financial Officer
Uninformative Buy
$669.00K
List of latest transactions for each holding click on a transaction to see Neha Krishnamohan's performance on stock

Neha Krishnamohan insider profile FAQ

What is the percentage of profitable transactions made by Neha Krishnamohan?
The percentage of profitable transactions made by Neha Krishnamohan is ―.
    What is the average return per transaction made by Neha Krishnamohan?
    The average return per transaction made by Neha Krishnamohan is ―.
      What stocks does Neha Krishnamohan hold?
      Neha Krishnamohan holds: KNTE, ARQT, ARTV stocks.
        What was Neha Krishnamohan’s latest transaction?
        Neha Krishnamohan latest transaction was an Uninformative Buy of ―.
          What was Neha Krishnamohan's most profitable transaction?
          Neha Krishnamohan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Neha Krishnamohan's role in Kinnate Biopharma?
            Neha Krishnamohan's role in Kinnate Biopharma is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.